| |
| |
|
| Insider
Information: |
Rubin Steven D |
| Relationship: |
Director |
| City: |
Miami |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
7,957,559 |
|
|
Indirect Shares
|
25,614,746 |
|
|
| Direct
Value |
$12,573,794 |
|
|
|
Indirect Value
|
$34,950,542 |
|
|
| Total
Shares |
33,572,305 |
|
|
| Total
Value |
$47,524,336 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
4
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
4.0
|
0.0
|
| Percentage
Gain/Loss : |
 17.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dreams Inc |
DRJ |
Director |
|
0 |
2006-11-15 |
192,308 |
Premium* |
|
|
Opko Health Inc |
OPK |
|
2024-01-05 |
6,187,732 |
2019-10-25 |
20,091,062 |
Premium* |
|
|
Asensus Surgical Inc |
ASXC |
Director |
2012-10-25 |
240,128 |
2012-10-25 |
785,383 |
Premium* |
|
|
Prolor Biotech Inc |
PBTH |
Director |
2013-08-29 |
0 |
|
0 |
Premium* |
|
|
Tiger X Medical Inc |
CDOM |
Interim CEO and Interi... |
2016-08-11 |
302,822 |
|
0 |
Premium* |
|
|
Castle Brands Inc |
ROX |
Director |
2019-10-08 |
0 |
|
0 |
Premium* |
|
|
Cocrystal Pharma |
COCP |
|
2016-03-15 |
733,484 |
2014-03-17 |
4,545,993 |
Premium* |
|
|
Fluent Inc |
FLNT |
Director |
2017-04-13 |
343,255 |
|
0 |
Premium* |
|
|
Red Violet Inc |
RDVT |
Director |
2023-11-30 |
143,138 |
2018-03-29 |
0 |
Premium* |
|
|
ChromaDex Corporation |
CDXC |
Director |
2023-05-25 |
7,000 |
2023-05-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OPK |
Opko Health Inc |
Executive VP-Administration |
• • – |
2014-04-11 |
4 |
D |
$8.87 |
$2,770,003 |
D/D |
(312,289) |
4,657,566 |
0 |
- |
|
| OPK |
Opko Health Inc |
Executive VP-Administration |
• • – |
2014-04-11 |
4 |
OE |
$1.65 |
$2,770,000 |
D/D |
700,000 |
4,969,855 |
0 |
- |
|
| OPK |
Opko Health Inc |
Executive VP-Administration |
• • – |
2015-01-31 |
4 |
D |
$11.62 |
$2,300,611 |
I/I |
(195,642) |
20,091,062 |
0 |
- |
|
| OPK |
Opko Health Inc |
Executive VP-Administration |
• • – |
2015-01-31 |
4 |
OE |
$0.00 |
$2,300,550 |
I/I |
4,796,158 |
20,286,704 |
0 |
- |
|
| OPK |
Opko Health Inc |
Executive VP-Administration |
• • – |
2016-05-03 |
4/A |
D |
$10.34 |
$1,252,753 |
D/D |
(121,156) |
5,571,251 |
0 |
- |
|
| OPK |
Opko Health Inc |
Executive VP-Administration |
• • – |
2017-04-12 |
4 |
D |
$7.66 |
$1,212,854 |
D/D |
(158,336) |
5,681,915 |
0 |
- |
|
| OPK |
Opko Health Inc |
Executive VP-Administration |
• • – |
2015-01-31 |
4 |
D |
$11.78 |
$886,796 |
D/D |
(75,299) |
5,439,407 |
0 |
- |
|
| OPK |
Opko Health Inc |
Executive VP-Administration |
• • – |
2015-01-31 |
4 |
OE |
$0.67 |
$886,744 |
D/D |
1,036,440 |
5,514,706 |
0 |
- |
|
| OPK |
Opko Health Inc |
Executive VP-Administration |
• • – |
2014-04-14 |
4 |
S |
$8.58 |
$857,700 |
D/D |
(100,000) |
4,557,566 |
0 |
- |
|
| OPK |
Opko Health Inc |
Executive VP-Administration |
• • – |
2014-04-15 |
4 |
S |
$8.10 |
$642,615 |
D/D |
(79,300) |
4,478,266 |
0 |
- |
|
| OPK |
Opko Health Inc |
Executive VP-Administration |
• • – |
2017-04-12 |
4 |
OE |
$2.36 |
$625,400 |
D/D |
265,000 |
5,840,251 |
0 |
- |
|
| ASXC |
Asensus Surgical Inc |
Director |
– • – |
2012-10-25 |
4 |
OE |
$0.25 |
$196,346 |
I/I |
785,383 |
785,383 |
0 |
- |
|
| ROX |
Castle Brands Inc |
Director |
– • – |
2019-10-08 |
4 |
D |
$1.27 |
$137,795 |
D/D |
(108,500) |
22,500 |
0 |
- |
|
| OPK |
Opko Health Inc |
Exec. VP - Admin. & Sec. |
• • – |
2007-07-13 |
4 |
B |
$1.80 |
$90,000 |
D/D |
50,000 |
4,145,581 |
2.81 |
- |
|
| COCP |
Cocrystal Pharma |
|
– • – |
2015-03-25 |
4 |
B |
$0.92 |
$50,000 |
D/D |
54,348 |
694,268 |
2.39 |
- |
|
| OPK |
Opko Health Inc |
Executive VP-Administration |
• • – |
2020-08-26 |
4 |
B |
$3.99 |
$39,943 |
D/D |
10,000 |
6,167,732 |
2.81 |
% |
|
| ROX |
Castle Brands Inc |
Director |
– • – |
2019-10-08 |
4 |
D |
$1.27 |
$28,575 |
D/D |
(22,500) |
0 |
0 |
- |
|
| OPK |
Opko Health Inc |
Executive VP-Administration |
• • – |
2013-05-01 |
4 |
B |
$6.45 |
$27,771 |
D/D |
4,300 |
4,195,468 |
2.81 |
- |
|
| PBTH |
Prolor Biotech Inc |
Director |
– • – |
2010-05-20 |
4 |
OE |
$0.50 |
$25,420 |
D/D |
45,420 |
73,086 |
0 |
- |
|
| OPK |
Opko Health Inc |
Executive VP - Administration |
• • – |
2007-12-04 |
4 |
B |
$1.84 |
$25,000 |
D/D |
13,587 |
4,159,168 |
2.81 |
- |
|
| OPK |
Opko Health Inc |
Executive VP - Administration |
• • – |
2008-05-08 |
4 |
B |
$1.25 |
$25,000 |
D/D |
20,000 |
4,189,168 |
2.81 |
- |
|
| OPK |
Opko Health Inc |
Executive VP-Administration |
• • – |
2015-08-20 |
4 |
B |
$12.40 |
$24,799 |
D/D |
2,000 |
5,441,407 |
2.81 |
- |
|
| ROX |
Castle Brands Inc |
Director |
– • – |
2019-01-16 |
4 |
OE |
$0.23 |
$23,000 |
D/D |
100,000 |
116,000 |
0 |
- |
|
| OPK |
Opko Health Inc |
Executive VP-Administration |
• • – |
2019-10-25 |
4 |
B |
$1.50 |
$22,500 |
D/D |
15,000 |
5,744,147 |
2.81 |
- |
|
| OPK |
Opko Health Inc |
Executive VP-Administration |
• • – |
2019-05-09 |
4 |
B |
$2.12 |
$21,442 |
D/D |
10,000 |
5,729,147 |
2.81 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
